Amyloid β-Protein (Human, 1-28)

Code:
4481-v
Name:
Amyloid β-Protein (Human, 1-28)
SP-28 (Human)
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys
(Trifluoroacetate Form)
(M.W. 3262.5) C145H209N41O46
Amyloidogenic Segment of Amyloid β-Protein
Package Price(Yen) Availability
Vial 0.5 mg 15,000 Ships within
1-3 business days
Bulk Request

main

Purity:
≧99.0% (HPLC)
Storage:
-20 ℃
Source:
Human

Solubility: H2O (0.1 mM)

more information

Category:
Biologically Active Peptides

reference

  1. D.A. Kirschner, H. Inouye, L.K. Duffy, A. Sinclair, M. Lind, and D.J. Selkoe, Proc. Natl. Acad. Sci. U.S.A., 84, 6953 (1987). (Original; Amyloid-Like Fibril Formation)
  2. B. Klajnert, M. Cortijo-Arellano, J. Cladera, and M. Bryszewska, Biochem. Biophys. Res. Commun., 345, 21 (2006). (Amyloid Fibril Formation)
  3. A. Perálvarez-Marin, A. Barth, and A. Gräslund, J. Mol. Biol., 379, 589 (2008). (Amyloid Fibril Formation)
  4. N.G.N. Milton and J.R. Harris, Micron, 40, 800 (2009). (Amyloid Fibril Formation)
  5. T. Wasiak, M. Ionov, K. Nieznanski, H. Nieznanska, O. Klementieva, M. Granell, J. Cladera, J.-P. Majoral, A.M. Caminade, and B. Klajnert, Mol. Pharm., 9, 458 (2012). (Amyloid Fibril Formation & Neurotoxity)
  6. J.S. Whitson, D.J. Selkoe, and C.W. Cotman, Science, 243, 1488 (1989). (Pharmacol.)
  7. B.A. Yankner, L.K. Duffy, and D.A. Kirschner, Science, 250, 279 (1990). (Pharmacol.)

Documents

PDF SDS: Japanese / English

Search other product
About Our Product
Technology


Scroll to top